SCHEMBL4066758

SCHEMBL4066758

NC(=O)C1Cc2ccccc2N(CC(=O)N2CCC(O)CC2)C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYGL P06737 1/20 0.50
ALDH1A1 P00352 4/20 0.48
MAPT P10636 2/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CHRM2 P08172 2/20 0.45
CHRM4 P08173 2/20 0.45
CHRM1 P11229 2/20 0.45
CHRM3 P20309 2/20 0.45
HSD17B10 Q99714 1/20 0.43
RAB9A P51151 1/20 0.41
CCKBR P32239 6/20 0.41
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4069396 0.93 CHRM2 (0.47) PYGLALDH1A1MAPTMEN1KMT2A
SCHEMBL4075040 0.90 CHRM2 (0.54) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL4075144 0.90 CHRM2 (0.51) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL4073094 0.87 CHRM2 (0.49) PYGLALDH1A1MAPTMEN1KMT2A
SCHEMBL4250746 0.86 MEN1 (0.53) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL4066622 0.86 CHRM2 (0.46) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL4066762 0.86 PYGL (0.54) PYGLALDH1A1MAPTMEN1KMT2A
SCHEMBL4064769 0.86 PYGL (0.49) PYGLALDH1A1MAPTMEN1KMT2A
SCHEMBL4072863 0.81 L3MBTL1 (0.46) PYGLALDH1A1MAPTMEN1KMT2A
SCHEMBL4069399 0.80 CHRM2 (0.48) PYGLALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LIMITED (GB) 2009-04-16 US disclosed
EP-1819332-B1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LTD (GB) 2009-03-11 EP disclosed
EP-1819332-A2 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES Prosidion Limited (GB) 2007-08-22 EP disclosed
WO-2006059164-A2 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LIMITED (GB) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PC, GOT2, PDK1 PYGL 104/4885ALDH1A1 397/4885MAPT 3617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.